Searched for
BIOCON STOCK NEWS
West Bengal's electronics factory push; Fed jitters hit TCSWest Bengal is exploring ways to expand electronics manufacturing under EMC 2.0. This and more in today's ETtech Top 5.
Ahead of Market: 10 things that will decide stock market action on WednesdayDomestic equity benchmarks ended lower on Tuesday, snapping a three-session rally amid profit booking in financial, realty and consumer sto...
Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...
Stocks in news: BSE, Britannia, Paytm, Meesho, RILIndian markets showed resilience, climbing despite volatility, buoyed by positive global trends and falling crude oil prices. Analysts anti...
Stocks in news: Paytm, Bajaj Auto, L&T, Bharti Airtel, Hero MotoCorpMarkets closed lower amid global headwinds and geopolitical worries. Several companies like Paytm, Bajaj Auto, and L&T are in focus due to ...
Syngene shares zoom 17% even as firm’s Q4 net profit drops 19% YoY. What's driving the surge?Syngene shares surged despite a 19% YoY decline in Q4FY26 net profit to Rs 148 crore, as earnings rebounded sharply from Rs 15 crore in the...
Stocks in news: TCS, HDFC Bank, ITC Hotels, Hyundai India, Adani EnterprisesMarkets surged for the fourth consecutive session, buoyed by favorable geopolitical cues. Key stocks like TCS, HDFC Bank, ITC Hotels, Hyund...
Biocon shares in focus after subsidiary launches biosimilar alternative to Stelara in the USBiocon Biologics has launched YESINTEK, a biosimilar to Stelara, in the United States for treating chronic autoimmune conditions, offering ...
HSBC sees Biocon share price rallying up to Rs 430; stock surges 5%Biocon Ltd shares rose 4.7% after HSBC upgraded its rating to "buy" and raised the target price to Rs 430. The upgrade reflects a turnaroun...
Buy Biocon, target price Rs 390: Axis SecuritiesBiocon Ltd., incorporated in the year 1978, is a Large Cap company (having a market cap of Rs 40868.42 Crore) operating in Pharmaceuticals ...
Buy Biocon, target price Rs 370: Anand RathiBiocon Ltd., incorporated in the year 1978, is a Large Cap company (having a market cap of Rs 37404.69 Crore) operating in Pharmaceuticals ...
Buy Biocon, target price Rs 340: Anand RathiBiocon Ltd. key Products/Revenue Segments include Bio Pharmaceuticals, Other Operating Revenue, Waste and Sale of services for the year end...
Biocon drops 4% as USFDA issues form 483 for 3 sitesAs per the US Food and Drug Administration (USFDA), Form 483 is issued to a firm's management at the conclusion of an inspection when an in...
Hold Biocon, target price Rs 380: ICICI DirectBiocon, incorporated in the year 1978, is a Large Cap company (having a market cap of Rs 44314.15 crore) operating in Pharmaceuticals secto...
Viatris deal pinches Biocon, but may prove a good betThe $3.3-billion acquisition - that includes $2.3 billion cash and a 12.9% equity stake in BBL - stands at over half of the market cap of B...
Biocon shares drop after French regulator finds lapses at its plantANSM has raised deficiencies concerning two biosimilar products intended in the treatment of cancer and one intended for diabetes.
D-Street may be ignoring Biocon’s growth risksThe stock price has priced in all the near-term positives arising from the business — leaving little room for any risks.
Biocon to stay buoyant going forward: Mehraboon IraniBullish on Biocon, recommend it even now before a dip: Mehraboon Irani.
- Biocon enters in partnership with Bristol-Myers Squibb; stock up
The stock has been in an uptrend this week and has moved nearly 5% higher, while for the month of November Biocon surged over 16%.
- Biocon can move up another 6% to 8%: Ambareesh Baliga
Those who have been holding on to this stock for a long time, it has been a bit of a underperformer if you see in the last 1-1.5 years. So ...